Table 1.
Characteristic | Patient values (N=101) |
---|---|
| |
Age, mean (SD) | 54.6 (13.6) |
| |
Female, n (%) | 42 (41.6) |
| |
Male, n (%) | 59 (58.4) |
| |
Caucasian, n (%) | 89 (88.1) |
| |
APACHE II, mean (SD) | 27.7 (9.3) |
| |
Charlson Comorbidity Index, median (IQR) | 1.5 (0, 2.3) |
| |
Admitting diagnosis, n (%) | |
• Sepsis/Septic Shock | 38 (37.6) |
• Airway protection, Other pulmonary | 26 (25.7) |
• COPD/Asthma | 15 (14.8) |
• Acute Lung Injury | 10 (9.9) |
• Transplants | 4 (4.0) |
• Metabolic Imbalance or Cirrhosis | 3 (3.0) |
• Cardiomyopathy or Arrhythmia | 2 (2.0) |
• Other reason | 3 (3.0) |
Abbreviations: ABCDE=Awakening and Breathing trial Coordination, Delirium assessment/management, Early mobility; APACHE II=Acute Physiology and Chronic Health Evaluation II; IQR=interquartile range; SD=standard deviation
Patient inclusion criteria include age ≥18 years, in one of the study ICUs with qualifying organ failure (i.e., mechanical ventilation, noninvasive ventilation, treatment for shock). This sample represents a population highly susceptible to the development of delirium and ICU-AW and require the full ABCDE bundle. Patient exclusion criteria included severe dementia, neurological injuries, pregnancy, moribund, active seizures, and prisoners.